Abstract
The inhibition of scorpion extracts on esophageal cancer and lung adenocarcinoma cells has been reported by previous studies, but the specific anti-tumor efficacy and potential molecular mechanism have not been clarified. In this study, we first modified the optimal enzymolysis and inactivation technology by imitating gastric and intestinal enzyme, and then investigated the antitumor effect of scorpion extracts both in vitro and in vivo. Our results showed that scorpion alcohol extraction with or without enzymolysis and fermentation could inhibit the cell proliferation of esophageal cancer and lung adenocarcinoma, and tumor growth in S180 tumor burden mice. In addition, the SOD activity increased by scorpion extracts, but MDA content decreased. The scorpion alcohol extracts without fermentation and enzymolysis exert inhibitory effect on the growth of esophageal cancer cells, and unenzymolytic fermented extracts have strong inhibitory effect on the growth of lung cancer cells. The scorpion and its extracts may serve as a new therapeutic agent to suppress tumor growth probably by promoting the function of immune organs and enhancing the activity of the immune system.
Keywords: Esophageal cancer, lung cancer, scorpion, therapy.
Graphical Abstract
Current Signal Transduction Therapy
Title:Scorpion Extracts Inhibit Tumor Growth in Esophageal Cancer and Lung Adenocarcinoma
Volume: 11 Issue: 1
Author(s): Yixuan Dong, Jihui Wang, Jing Li and Wei Li
Affiliation:
Keywords: Esophageal cancer, lung cancer, scorpion, therapy.
Abstract: The inhibition of scorpion extracts on esophageal cancer and lung adenocarcinoma cells has been reported by previous studies, but the specific anti-tumor efficacy and potential molecular mechanism have not been clarified. In this study, we first modified the optimal enzymolysis and inactivation technology by imitating gastric and intestinal enzyme, and then investigated the antitumor effect of scorpion extracts both in vitro and in vivo. Our results showed that scorpion alcohol extraction with or without enzymolysis and fermentation could inhibit the cell proliferation of esophageal cancer and lung adenocarcinoma, and tumor growth in S180 tumor burden mice. In addition, the SOD activity increased by scorpion extracts, but MDA content decreased. The scorpion alcohol extracts without fermentation and enzymolysis exert inhibitory effect on the growth of esophageal cancer cells, and unenzymolytic fermented extracts have strong inhibitory effect on the growth of lung cancer cells. The scorpion and its extracts may serve as a new therapeutic agent to suppress tumor growth probably by promoting the function of immune organs and enhancing the activity of the immune system.
Export Options
About this article
Cite this article as:
Dong Yixuan, Wang Jihui, Li Jing and Li Wei, Scorpion Extracts Inhibit Tumor Growth in Esophageal Cancer and Lung Adenocarcinoma, Current Signal Transduction Therapy 2016; 11 (1) . https://dx.doi.org/10.2174/1574362411666160210232741
DOI https://dx.doi.org/10.2174/1574362411666160210232741 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
DNA Methylation Biomarkers in Serum for Gastric Cancer Screening
Mini-Reviews in Medicinal Chemistry Role of Carboplatin in the Treatment of Triple Negative Early- Stage Breast Cancer
Reviews on Recent Clinical Trials Pharmacological Properties of Indazole Derivatives: Recent Developments
Mini-Reviews in Medicinal Chemistry Identification of Small Molecule Sulfonic Acids as Ecto-5'-Nucleotidase Inhibitors
Medicinal Chemistry Targeting miR-21 Induces Autophagy and Chemosensitivity of Leukemia Cells
Current Drug Targets New Insights into Binding Interfaces of Coagulation Factors V and VIII and their Homologues - Lessons from High Resolution Crystal Structures
Current Protein & Peptide Science Implications of Melatonin Therapy in Irritable Bowel Syndrome: A Systematic Review
Current Pharmaceutical Design Treat to Target for Osteoporosis: Another Step Forward
Current Rheumatology Reviews Theranostics Based on Iron Oxide and Gold Nanoparticles for Imaging- Guided Photothermal and Photodynamic Therapy of Cancer
Current Topics in Medicinal Chemistry Genomics of Addiction
Current Psychiatry Reviews Recent Advances in Developing Photosensitizers for Photodynamic Cancer Therapy
Combinatorial Chemistry & High Throughput Screening Common Pathways in Health Benefit Properties of RSV in Cardiovascular Diseases, Cancers and Degenerative Pathologies
Current Pharmaceutical Biotechnology Long Non-coding RNA and microRNAs as Novel Potential Biomarker and Therapeutic Target in the Treatment of Gastrointestinal Cancers
Current Pharmaceutical Design Histone Modifications, Stem Cells and Prostate Cancer
Current Pharmaceutical Design Radiation Oncology and Molecular-Targeted Therapy for EGFR and its Signal Transduction Pathways: Molecular Basis and Clinical Application for Improvement of Radiotherapeutic Outcomes
Current Signal Transduction Therapy Mechanisms of Drug Resistance in Cancer Chemotherapy: Coordinated Role and Regulation of Efflux Transporters and Metabolizing Enzymes
Current Pharmaceutical Design A Synopsis on the Role of Human Papilloma Virus Infection in Cervical Cancer
Current Drug Metabolism Antiangiogenesis Drug Design: Multiple Pathways Targeting Tumor Vasculature
Current Medicinal Chemistry Evolution of the Strategies for Screening and Identifying Human Tumor Antigens
Current Protein & Peptide Science Dual Roles of Sulforaphane in Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry